Cargando…
Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil»
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427426/ http://dx.doi.org/10.1016/j.bjid.2013.05.001 |
| _version_ | 1784778899561906176 |
|---|---|
| author | Ernesto Vidal, José Tung Wan Song, Alice Laura Matos, Maria Bartmann, Daniel dos Anjos, Guilherme José Peixoto de Miranda, Érique Carvalho Freitas, Ângela de Freitas Dalben, Mirian Santana, Claudinei Cotrim Segurado, Aluísio Cortese Barreto, Cláudia Vladimir Hernández, Adrián |
| author_facet | Ernesto Vidal, José Tung Wan Song, Alice Laura Matos, Maria Bartmann, Daniel dos Anjos, Guilherme José Peixoto de Miranda, Érique Carvalho Freitas, Ângela de Freitas Dalben, Mirian Santana, Claudinei Cotrim Segurado, Aluísio Cortese Barreto, Cláudia Vladimir Hernández, Adrián |
| author_sort | Ernesto Vidal, José |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9427426 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94274262022-09-01 Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» Ernesto Vidal, José Tung Wan Song, Alice Laura Matos, Maria Bartmann, Daniel dos Anjos, Guilherme José Peixoto de Miranda, Érique Carvalho Freitas, Ângela de Freitas Dalben, Mirian Santana, Claudinei Cotrim Segurado, Aluísio Cortese Barreto, Cláudia Vladimir Hernández, Adrián Braz J Infect Dis Erratum Elsevier 2013-05-29 /pmc/articles/PMC9427426/ http://dx.doi.org/10.1016/j.bjid.2013.05.001 Text en © 2013 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Erratum Ernesto Vidal, José Tung Wan Song, Alice Laura Matos, Maria Bartmann, Daniel dos Anjos, Guilherme José Peixoto de Miranda, Érique Carvalho Freitas, Ângela de Freitas Dalben, Mirian Santana, Claudinei Cotrim Segurado, Aluísio Cortese Barreto, Cláudia Vladimir Hernández, Adrián Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title | Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title_full | Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title_fullStr | Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title_full_unstemmed | Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title_short | Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil» |
| title_sort | erratum in «high rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced hiv-infected patients: results of a prospective cohort study in são paulo, brazil» |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427426/ http://dx.doi.org/10.1016/j.bjid.2013.05.001 |
| work_keys_str_mv | AT ernestovidaljose erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT tungwansongalice erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT lauramatosmaria erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT bartmanndaniel erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT dosanjosguilherme erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT josepeixotodemirandaerique erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT carvalhofreitasangela erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT defreitasdalbenmirian erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT santanaclaudinei erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT cotrimseguradoaluisio erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT cortesebarretoclaudia erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil AT vladimirhernandezadrian erratuminhighrateofvirologicsupressionwithdarunavirritonavirplusoptimazedbackgroundtherapyamonghighlyantiretroviralexperiencedhivinfectedpatientsresultsofaprospectivecohortstudyinsaopaulobrazil |